Cargando…
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method
BACKGROUND: In this study, pretargeted immuno-positron-emission tomography [PET] with a bispecific monoclonal anti-carcinoembryonic antigen [CEA] (CEACAM5) × anti-hapten antibody (bispecific monoclonal antibody [bsmAb]) and a small (1.5 kD) peptide labeled with (68)Ga was compared to fludeoxyglucose...
Autores principales: | Schoffelen, Rafke, van der Graaf, Winette TA, Sharkey, Robert M, Franssen, Gerben M, McBride, William J, Chang, Chien-Hsing, Laverman, Peter, Goldenberg, David M, Oyen, Wim JG, Boerman, Otto C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298693/ https://www.ncbi.nlm.nih.gov/pubmed/22284761 http://dx.doi.org/10.1186/2191-219X-2-5 |
Ejemplares similares
-
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results
por: Schoffelen, R, et al.
Publicado: (2013) -
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy
por: Woliner-van der Weg, Wietske, et al.
Publicado: (2015) -
A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer
por: Elekonawo, Fortuné M. K., et al.
Publicado: (2019) -
Pretargeted Molecular Imaging and Radioimmunotherapy
por: Goldenberg, David M., et al.
Publicado: (2012) -
Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
por: Bodet-Milin, Caroline, et al.
Publicado: (2015)